Lee Moa P, Glynn Robert J, Schneeweiss Sebastian, Lin Kueiyu Joshua, Patorno Elisabetta, Barberio Julie, Levin Raisa, Evers Thomas, Wang Shirley V, Desai Rishi J
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital & Harvard Medical School, Boston, MA, USA.
Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.
Clin Epidemiol. 2020 Jun 15;12:607-616. doi: 10.2147/CLEP.S253612. eCollection 2020.
The differential impact of various demographic characteristics and comorbid conditions on development of heart failure (HF) with preserved (pEF) and reduced ejection fraction (rEF) is not well studied among the elderly.
Using Medicare claims data linked to electronic health records, we conducted an observational cohort study of individuals ≥65 years of age without HF. A Cox proportional hazards model accounting for competing risk of HFrEF and HFpEF incidence was constructed. A gradient-boosted model (GBM) assessed the relative influence (RI) of each predictor in the development of HFrEF and HFpEF.
Among 138,388 included individuals, 9701 developed HF (incidence rate = 20.9 per 1000 person-years). Males were more likely to develop HFrEF than HFpEF (HR = 2.07, 95% CI: 1.81-2.37 vs. 1.11, 95% CI: 1.02-1.20, for heterogeneity <0.01). Atrial fibrillation and pulmonary hypertension had stronger associations with the risk of HFpEF (HR = 2.02, 95% CI: 1.80-2.26 and 1.66, 95% CI: 1.23-2.22) while cardiomyopathy and myocardial infarction were more strongly associated with HFrEF (HR = 4.37, 95% CI: 3.21-5.97 and 1.94, 95% CI: 1.23-3.07). Age was the strongest predictor across all HF subtypes with RI from GBM >35%. Atrial fibrillation was the most influential comorbidity for the development of HFpEF (RI = 8.4%) while cardiomyopathy was the most influential comorbidity for the development of HFrEF (RI = 20.7%).
These findings of heterogeneous relationships between several important risk factors and heart failure types underline the potential differences in the etiology of HFpEF and HFrEF.
在老年人中,各种人口统计学特征和合并症对射血分数保留的心力衰竭(HFpEF)和射血分数降低的心力衰竭(HFrEF)发生发展的差异影响尚未得到充分研究。
利用与电子健康记录相关联的医疗保险索赔数据,我们对年龄≥65岁且无心力衰竭的个体进行了一项观察性队列研究。构建了一个考虑HFrEF和HFpEF发病竞争风险的Cox比例风险模型。一个梯度提升模型(GBM)评估了每个预测因素在HFrEF和HFpEF发生发展中的相对影响(RI)。
在纳入的138,388名个体中,9701人发生了心力衰竭(发病率=每1000人年20.9例)。男性发生HFrEF的可能性高于HFpEF(HR = 2.07,95%CI:1.81 - 2.37;相比之下,HR = 1.11,95%CI:1.02 - 1.20,异质性<0.01)。心房颤动和肺动脉高压与HFpEF风险的关联更强(HR = 2.02,95%CI:1.80 - 2.26和1.66,95%CI:1.23 - 2.22),而心肌病和心肌梗死与HFrEF的关联更强(HR = 4.37,95%CI:3.21 - 5.97和1.94,95%CI:1.23 - 3.07)。年龄是所有心力衰竭亚型中最强的预测因素,GBM的RI>35%。心房颤动是HFpEF发生发展中最有影响的合并症(RI = 8.4%),而心肌病是HFrEF发生发展中最有影响的合并症(RI = 20.7%)。
这些关于几个重要危险因素与心力衰竭类型之间异质性关系的发现强调了HFpEF和HFrEF病因学上的潜在差异。